{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:48Z","timestamp":1792795008519,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/ndt\/gfy077","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T20:11:13Z","timestamp":1521231073000},"page":"1472-1480","source":"Crossref","is-referenced-by-count":32,"title":["Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review"],"prefix":"10.1093","volume":"33","author":[{"given":"Ankit","family":"Sharma","sequence":"first","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"},{"name":"School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R","family":"Lewis","sequence":"additional","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"},{"name":"School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia"},{"name":"School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai H","family":"Lim","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia"},{"name":"Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetonia","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Otago, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R","family":"Chapman","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Hospital, Westmead, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I","family":"Alexander","sequence":"additional","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"},{"name":"School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Kidney Research, Children\u2019s Hospital at Westmead, Westmead, Australia"},{"name":"School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"key\n\t\t\t\t20180801040023_gfy077-B1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1600-6143.2007.01759.x","article-title":"Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome","volume":"7","author":"McDonald","year":"2007","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B2","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.kint.2016.10.040","article-title":"Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent\/recurrent versus de novo donor-specific antibodies","volume":"91","author":"Haas","year":"2017","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/TP.0000000000000216","article-title":"De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation","volume":"98","author":"Heilman","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.humimm.2006.07.011","article-title":"Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays\u2013single-center experience","volume":"67","author":"Mihaylova","year":"2006","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity by de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","author":"Comoli","year":"2016","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B13"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B15","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/ajt.14161","article-title":"The value of protocol biopsies to identify patients with de novo donor-specific antibody at high risk for allograft loss","volume":"17","author":"Schinstock","year":"2017","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.14015","article-title":"Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival","volume":"17","author":"Wiebe","year":"2017","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.TP.0000443226.74584.03","article-title":"High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction","volume":"97","author":"Cooper","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about?","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B24","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/TP.0000000000001705","article-title":"Epitope-based HLA matching: a useful strategy with many shortcomings to overcome","volume":"101","author":"Claas","year":"2017","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B25","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/TP.0000000000001284","article-title":"Strategic use of epitope matching to improve outcomes","volume":"100","author":"Wiebe","year":"2016","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B26","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B27","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B29","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/TP.0000000000001487","article-title":"Clinical outcome of patients with de novo C1q-binding donor-specific HLA antibodies after renal transplantation","volume":"101","author":"Bamoulid","year":"2017","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.TP.0000441362.11232.48","article-title":"Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients","volume":"97","author":"Everly","year":"2014","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.humimm.2011.07.303","article-title":"High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes","volume":"72","author":"Kosmoliaptsis","year":"2011","journal-title":"Hum Immunol"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TP.0b013e31824612df","article-title":"Durability of antibody removal following proteasome inhibitor-based therapy","volume":"93","author":"Everly","year":"2012","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20180801040023_gfy077-B35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients","volume":"100","author":"O'Leary","year":"2016","journal-title":"Transplantation"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/8\/1472\/25198520\/gfy077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T11:18:20Z","timestamp":1603970300000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/8\/1472\/4967842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,4,11]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy077","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,4,11]]}}}